The chief scientific officer of cell therapy at Poseida Therapeutics discussed the company’s CAR-T and TCR technologies.
Devon J. Shedlock, PhD
Advertisement
Articles by Devon J. Shedlock, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – December 3, 2025
2
Lessons Learned From the Past 25 Years of Cell and Gene Therapy Research
3
Autologous Stem Cell Therapy for Alzheimer Disease Advances to Phase 2 After Positive Early Findings
4
FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma
5
